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Abstract  Dicalcium phosphate dihydrate (DCPD) Brushite coatings composed of flower-like structures were formed on 
magnesium substrates via a straightforward chemical immersion technique in order to slow down the corrosion rate of the 
metallic substrates. Moreover, the synthesised DCPD coatings were also converted to hydroxyapatite (HAP) coating using a 
low-temperature hydrothermal process to further investigate their ability to reduce the corrosion rate of the substrates in 
phosphate buffer saline (PBS) and Ringer’s solutions. Degradation studies found DCPD coatings were capable of providing 
the most significant reduction in the corrosion rate of around 0.100 mm/yr compared to 3.828 mm/yr for the uncoated 
substrates soaked in Ringer’s solution at 37ºC. 
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1. Introduction 
Ideally, orthopaedic and dental devices must have a 
surface chemistry and physical structure that is biological 
compatible. In addition, they must also induce a positive 
osteogenic response and avoid any unfavourable immune 
responses [1]. Biodegradable implant materials currently in 
use and under development offer many attractive features 
for a number of clinical applications such as bone fixation, 
controlled release of pharmaceuticals, endovascular stents 
and orthopaedic implants [2-4]. The use of biodegradable 
materials in orthopaedic surgical procedures is of particular 
interest, since the function of many implants usually comes 
to an end when tissue regeneration and healing has taken 
place [3, 5]. The majority of these implants are biologically 
inert and engineered from metallic materials such as 
cobalt-chromium based alloys, stainless steels and titanium 
alloys. Metallic materials are very appealing for load 
bearing applications due to their ductility, high strength, 
fracture toughness and anticorrosion properties [6-8]. 
Typically, many of these implants are only needed for a 
short period of time to provide the necessary structural and 
mechanical support during tissue regeneration. However, to 
remove the implant after tissue regeneration requires a 
second surgical procedure. The additional surgical 
procedure is both costly and significantly increases the risk  
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of infection and scarring of the patient [9]. Alternatively, 
the implant can be left in situ and as a result a number of 
potentially detrimental effects can take place such as 
corrosion of the implant material itself, inflammatory 
responses, stress-shielding and subsequent weakening of 
surrounding tissues. For example, there can be a significant 
release of toxic metallic ions such as chromium, cobalt and 
nickel during biological corrosion and mechanical wear. 
The production of these toxic metallic ions immediately 
solicits an unfavourable inflammatory response from the 
body’s immune system. The unfavourable immune response 
significantly reduces the biocompatibility of the implant 
and often leads to secondary revision surgery [10-12]. The 
other major disadvantage of metallic implants is their 
superior mechanical properties that are often many times 
greater than those of natural bone tissues. For instance, 
cobalt-chromium based alloys can have an elastic modulus 
that is ten times greater than that of bone and titanium based 
alloys are typically five times greater [6, 13, 14]. The 
significant difference between the mechanical properties of 
the implant and the surrounding bone creates a 
stress-shielding effect that causes bone resorption and 
subsequent implant failure. Furthermore, metallic implants 
are biologically inert and do not biologically or chemically 
interact with the surrounding tissues. The lack of interaction 
results in very little interfacial bonding or osteointegration 
taking place [15]. One currently used technique to improve 
the osteointegration of metallic implants involves coating 
them with a bioactive material such as calcium phosphate 
[16]. 
An attractive alternative to conventional metallic 
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implants is to develop a biologically degradable implant 
that achieves complete dissolution by the end of the tissue 
regeneration period [17]. Some successful outcomes have 
been achieved using biodegradable polymers in applications 
such as sutures, bone and dental cements, bone grafting 
materials, plates, screws, pins and fixation devices [18-24]. 
However, their low mechanical strength means they are 
only suitable for low-load bearing applications and soft 
tissue reconstruction. On the other hand magnesium (Mg) is 
a metallic material with the potential to overcome the 
limitations of conventional metallic implant materials and 
degradable polymeric materials. Magnesium offers a 
number of attractive features such as biocompatibility, 
biodegradability and mechanical properties similar to bone 
[25]. The density of Mg is 1.74 g/cm3 at 20℃ and is 
slightly less than bone which ranges from 1.8 to 2.1 g/cm3. 
There is also a close similarity between the elastic modulus 
of Mg (45 GPa) and bone which varies from 40 to 57 GPa 
[26, 27]. The close similarity of its mechanical properties 
and its favourable biocompatibility makes Mg a promising 
material for the development of biodegradable orthopaedic 
implants [25, 28]. 
Despite Mg many advantages, but its poor corrosion 
resistance in chloride rich body fluids (pH ranges between 
7.4 and 7.6) has severely limited its use in medical 
applications. The rapid corrosion rate results in two 
fundamental problems. The first involves the rapid 
formation of subcutaneous hydrogen gas bubbles that 
appear during the first week after surgery [29, 30]. However, 
the bubbles can be drawn off using a subcutaneous needle 
[31]. The second problem results in the loss of mechanical 
integrity between the implant and the surrounding bone 
tissue that prevents effective tissue regeneration. However, 
this vulnerability to corrosion can be considered as an 
advantage when designing a biodegradable implant. For 
example, controlled degradation of the implant will allow 
natural bone tissues to regenerate and replace the implant 
[32]. Generally, Mg corrodes in an aqueous environments 
according to the following equations. The anodic reaction 
can be explained by the partial reaction expressed in 
equation (1). While the partial reaction occurring at the 
cathode can be expressed by equation (2).  
Anodic reaction: Mg → Mg2- + 2e-         (1) 
Cathodic reaction: 2H2O + 2e- → 2OH- + H2     (2) 
The complete corrosion process is presented in equation 
(3). However, corrosion occurring in the body environment 
is not straight forward and is complicated by the influence 
of factors such as: 1) the pH of body fluids; 2) variations in 
the pH value; 3) concentration of ions; 4) the presence of 
proteins and protein adsorption on the surface of the 
implant material; and 5) the influence of the surrounding 
tissues [25, 33, 34]. 
Mg (s) + 2H2O (l) → Mg (OH)2 (s) + H2 (g)     (3) 
The most significant by-products produced during 
degradation are hydrogen gas and Mg ions. Studies by Song 
have suggested that hydrogen levels of around 0.01 ml/cm2/ 
day does not constitute a serious threat to body tissues [35]. 
While other studies have shown the release of Mg ions can 
promote cellular adhesion and cellular differentiation of 
bone cells [36, 37]. Another positive effect resulting from 
the release of Mg ions is their antibacterial properties that 
have the potential to prevent biological film formation on 
implant surfaces [38]. The results of the studies clearly 
indicate reducing the corrosion rate will reduce the 
formation levels of Mg ions and hydrogen to acceptable 
levels and make Mg an ideal biodegradable implant 
material. One effective method of reducing the corrosion 
rate is to coat it with a non-corrosive protective layer. 
Therefore, developing an effective biocompatible coatings 
capable of regulating the corrosion rate is essential for the 
development of a biodegradable Mg implants.  
Calcium phosphates (CaP) have been widely used to coat 
metal implants because of their excellent biocompatibility, 
non-toxicity, bioactivity and bone inductivity properties. 
Several techniques have been used to deposit CaP coating 
on Mg and other metal substrate materials such as 
anodization [39], biomimetic methods [40], electro-less 
deposition [41], electro-deposition [42, 43], ion-beam-assist
ed deposition [44], chemical [45, 46] and hydrothermal [47]. 
Many of these techniques require complex equipment, 
multiple processing steps and high temperature treatments 
to produce an effective substrate coating. 
In this study a straightforward and cost effective 
chemical immersion technique was used to deposit 
di-calcium phosphate dehydrate or brushite [DCPD; 
CaHPO4.2H2O] coatings on Mg substrates. The DCPD 
coatings were subsequently converted into hydroxyapatite 
[(HAP); Ca10(OH)2 (PO4)6] via immersion in a sodium 
hydroxide solution at 80 ºC for 2h. The size, morphology 
and crystallinity of both DCPD and HAP coating were 
examined using X-ray diffraction (XRD) spectroscopy, 
Field emission scanning electron microscopy (FESEM), 
Energy Dispersive Spectroscopy (EDS) and Fourier 
Transform Infrared spectroscopy (FT-IR). The degradation 
behaviour of Mg and Mg coated substrates were evaluated 
in phosphate buffer saline (PBS) solution and Ringer’s 
solution at body temperature (37ºC).  
2. Materials and Methods 
2.1. Materials 
All chemicals used in this work were supplied by 
Chem-Supply (Australia) and all aqueous solutions were 
made using Milli-Q® water (18.3 MΩ cm-1) produced by an 
ultrapure water system (Barnstead Ultrapure Water System 
D11931; Thermo Scientific, Dubuque, IA). 
2.2. Mg Substrate Pre-treatment 
Mg (99.9% pure) sheets were cut into rectangular strips 
40 mm in length, 3 mm in width and 0.15 mm in thickness. 
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The strips were polished using 1200 grit silicon carbide 
(SiC) paper to remove all surface oxides and contaminants. 
After polishing, the strips were cleaned in a 5 wt% nitric 
acid (HNO3) solution followed by ultrasonically rinsing in 
acetone for 10 min. The acetone was then lightly rinsed 
from the substrates using Milli-Q® water before being 
allowed to air dry. After drying the weight of each substrate 
was recorded using an Ohaus PA214C microbalance. 
2.3. Substrate Surface Treatment 
The electrolyte used to form the DCPD coatings was 
prepared by adding 0.32 M of Ca(NO3)2 and 0.19 M of 
KH2PO4 to 100 mL of Milli-Q® water. The mixture was 
then thoroughly stirred at 400 rpm for 10 min. The 
electrolyte was prepared at 25 ± 1ºC and the resulting pH 
was 4. DCPD coating were prepared by immersing in the 
prepared electrolyte. Individual substrates were removed 
from the electrolyte at pre-determined time intervals (3, 15, 
30, 60, and 180) so that the size and morphology of the 
forming coating could be quantified using advanced 
characterisation techniques. At the end of each immersion 
period samples were removed from the electrolytic solution, 
washed in Milli-Q® water, and then allowed to air dry for 
24 h. Conversion of DCPD coatings to hydroxyapatite 
(HAP) was achieved by immersing the DCPD coated 
substrates into a 1M solution of sodium hydroxide (NaOH) 
at 80ºC for 2 h. At the end of this period substrates were 
removed from the electrolyte solution, washed in Milli-Q® 
water, and then allowed to air dry for at least 24 h. The 
HAP coatings were then examined using the advanced 
characterisation techniques discussed below.  
2.4. Corrosion Testing  
The corrosion resistance of coated and non-coated Mg 
substrates were tested in freshly prepared phosphate buffer 
saline (PBS) solution and Ringer’s solution. The 
composition of the PBS solution (in g/L) consisted of 8.006 
NaCl, 0.201 KCl, 1.420 Na2HPO4 and 0.240 KH2PO4. The 
Ringer’s solution composition (in g/L) consisted of 8.6 
NaCl, 0.6 KCl and 0.66 CaCl2. 2H2O. The pH of the 
respective solutions were adjusted to 7.4 and maintained at 
37ºC during the corrosion studies to match body fluid pH 
and temperature. Polarization curves were generated using 
an EG&G Princeton Potentiostat/galvanostat (Model 273A, 
supplied EG&G Princeton applied research) configured for 
a three-electrode experimental set-up. The working 
electrode in all corrosion tests consisted of a test substrate 
with a surface area of 1 cm2. A saturated calomel electrode 
(SCE) was used as the reference electrode and a platinum 
wire (Pt) was used as the counter electrode. A Tafel test 
procedure was performed over a voltage range from -2.5 V 
up to 1.0 V, with a step size of 10 mV and a 1s time interval 
for the 10 mV scan rate. From the resulting experimentally 
derived polarization curves parameters such as corrosion 
potential (Ecorr), corrosion current density (Icorr), anodic/ 
cathodic Tafel slopes (βa and βa) and corrosion rate were 
derived. The polarization resistance (Rp) was calculated at 




2.303 𝐼𝐼𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐  (𝛽𝛽𝑎𝑎+𝛽𝛽𝑐𝑐  )
           (4) 
2.5. Advanced Characterisation Techniques  
2.5.1. X-ray Diffraction (XRD) Spectroscopy  
XRD spectroscopy technique was used to examine and 
identify crystalline size and phases present in the surface 
coating. Spectroscopy data was recorded at room 
temperature, using a GBC® eMMA X-ray Powder 
Diffractometer [Cu Kα = 1.5406 Å radiation source] 
operating at 35 kV and 28 mA. The diffraction patterns 
were collected over a 2θ range of 20° to 60° with an 
incremental step size of 0.02° using flat plane geometry 
with 2 second acquisition time for each scan.  
2.5.2. Scanning Electron Microscopy (SEM) and Energy 
Dispersive Spectroscopy (EDS) 
The SEM technique was used to study the size, shape and 
morphological features of the surface coating formed on the 
substrates during the immersion process. All micrographs 
were taken using a JCM-6000, NeoScopeTM with an 
attached energy dispersive X-ray spectroscopy function. 
Samples were mounted on individual substrate holders 
using carbon adhesive tape before being sputter coated with 
a 2 nm layer of gold to prevent charge build up using a 
Cressington 208HR High Resolution Sputter coater. 
2.5.3. Transmission Electron Microscopy (TEM) 
The size, morphology and topography of DCPD particles 
formed were investigated using TEM. Sample preparation 
consisted removing a portion of the coating from the 
surface of the substrate. The samples were then placed into 
small tubes containing Milli-Q® water. The tubes were then 
sealed and placed into an ultrasonic bath for 10 minutes. 
The suspensions were then filtered 2 times before a single 
drop from each sample was deposited onto its respective 
carbon-coated copper TEM grid using a micropipette. The 
samples were then allowed to slowly dry over a 24-hour 
period. After sample preparation a bright field TEM study 
was carried out using a Phillips CM-100 electron 
microscope (Phillips Corporation Eindhoven, The 
Netherlands) operating at 80kV.  
2.5.4. Fourier Transform Infrared Spectroscopy (FT-IR) 
FT-IR spectroscopy was used to investigate CaP powders 
synthesized during the immersion process using a 
Perkin–Elmer Frontier FT-IR spectrometer with Universal 
Single bounce Diamond ATR attachment. FT-IR spectra 
were recorded in the range from 525 to 4000cm−1 in steps of 
4 cm-1. 
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3. Results and Discussions 
3.1. XRD Analysis of Calcium Phosphate Formation on 
Substrates 
Before chemical immersion a representative Mg substrate 
was examined using the XRD technique [49]. The resulting 
Mg XRD pattern is presented in Figure 1 (c) and confirms 
the substrate purity. The XRD pattern also revealed that 
there was no contamination present on the substrate surface. 
XRD analysis was also carried out on chemically treated 
substrates. Figure 1 (b) presents a typical XRD pattern of a 
substrate after an immersion period of 180 min. Analysis of 
pattern (b) reveals the presence of a crystalline calcium 
phosphate phase identified as di-calcium phosphate 
di-hydrate (DCPD) or Brushite (JCPDS 11-293). No other 
calcium phosphate phases were found in the samples. 
However, the XRD analysis did confirm the presence of Mg 
peaks (002), (101) and (102) produced by the underlying 
substrate. The coating produced during immersion was 
formed via the following reaction [9, 48]:  
HPO42− + Ca2+ + 2H2O → CaHPO4.2H2O      (5) 
 
Figure 1.  XRD patterns for uncoated and coated substrates: (a) 
hydroxyapatite coating converted from a DCPD coating; (b) DCPD coating, 
and (c) pure magnesium substrate 
Typically, the mass of DCPD formed during a 180 min 
immersion period was collected, dried and weighed. The 
mass was found to be 3.5 mg [Figure 3 (d)] and equated to a 
coating thickness of around 10 µm. In the next stage of the 
study, the DCPD coatings were converted into HAP by 
immersing in a 1M solution of sodium hydroxide at 80 ºC 
for 2 h. A representative XRD pattern for the converted 
coating is presented in Figure 1 (a). Analysis of the pattern 
reveals the DCPD coating was fully converted, and the 
HAP phases present were consistent with phases listed in 
the ICDD database. Also present are the Mg peaks seen in 
the earlier DCPD coatings. The consistent presence of Mg 
peaks suggests that the coating was unable to fully mask the 
underlining substrate due to regions of poor surface 
coverage. The surface coverage was further investigated 
using SEM analysis and discussed in the following section.  
3.2. SEM and EDS Analysis of Coating Formation 
The size, morphology and topographical features of the 
deposited DCPD coatings were examined using SEM and 
the composition of the coatings were investigated using 
EDS spectroscopy. Figure 2 presents a series of SEM 
micrographs taken during the formation of a typical DCPD 
coating at immersion periods of 3, 15, 30, 60, and 180 min. 
Figure 2 (a) is a micrograph of a representative Mg 
substrate prior to chemical immersion. Micrograph 2 (b) 
was taken after a 3 min immersion period. The image 
reveals the presence of scattered individual small DCPD 
plate assemblies that are typically around 50 µm in size. 
After 15 minutes the scattered plate-like assemblies are 
beginning to grown into flower-like features. At this point 
in time the features are around 150 µm in size as seen in 
Figure 2 (c). For an immersion period of 30 min, the 
flower-like features have grown in size and are starting to 
merge with nearby neighbours as seen in Figure 2 (d). Also 
clearly visible at this stage were large areas of exposed 
underlining substrate. Following a further 30 minutes of 
immersion, the flower-like features completely cover the 
substrate surface as seen in Figures 2 (e) and 3 (a). An 
enlarged view of the flower-like petals is presented in 
Figure 3 (b), while Figure 3 (c) presents a detailed end view 
of the petals showing their plate-like structure. Typically, at 
the end of a 180 min immersion period substrates were 
completely covered with large flower-like features typically 
around 500 to 700 µm in size as seen in Figure 2 (f). 
 
Figure 2.  (a) Cleaned magnesium substrate and subsequent formation of 
DCPD coating after electrolyte immersion periods of (b) 3; (c) 15; (d) 30; 
(e) 60, and (f) 180 min 
The coating formation rate varied over the 180 minute 
immersion period and is graphically presented in Figure 3 
(d). Initially the formation rate was rapid during the first 60 
minutes of immersion. Between 60 to 120 minutes the 
formation rate started slowing down and after 120 minutes 
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it was significantly reduced as reflected in the levelling off 
seen in Figure 3 (d). Also seen during the later part of the 
immersion period was the significant reduction in the 
evolution of gas bubbles. The significant reduction in 
formation rate and gas evolution suggests the coating was 
able to impede the flow of electrolyte towards the substrate 
surface. Thus, the levelling off seen in Figure 3 (d) after 
180 minutes indicates that the coatings were providing 
some degree of protection to the underlining substrate.  
Analysis of DCPD coatings using EDS spectroscopy 
revealed that they contained elements such as Ca, O and P 
but no Mg. The analysis indicates that Mg ions were not 
substituted for Ca ions during the formation of the DCPD 
coating.  
 
Figure 3.  (a) DCPD (brushite) coating decorated with ornate flowers covering the entire substrate surface; (b) enlarged view of flower petals; (c) 
detailed end view of DCPD crystal plates forming the petal structure, and (d) mass of DCPD coating formed with increasing immersion periods 
 
Figure 4.  (a) a representative SEM micrograph of a DCPD flower decorating the coating; (b) EDS analysis of the flower showing its elemental 
composition; (c) a typical SEM micrograph taken after the conversion to form HAP, and (d) EDS analysis of the coating after conversion 
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Moreover, the EDS analysis confirms that the Mg peaks 
seen in the XRD patterns were the result of the underlining 
substrate and not Mg in the coating. Figure 4 (a) presents a 
representative SEM micrograph of a DCPD flower-like 
structure forming part of the coating, while Figure 4 (b) 
presents the results of the EDS analysis and the elemental 
breakdown of components present in the coating.  
Figure 4 (c) and (d) present a representative set of results 
confirming that the conversion process had converted the 
DCPD coatings into HAP. Figure 4 (d) presents the results 
of the EDS analysis and the elemental breakdown of the 
components present in the converted HAP coating. The 
analysis revealed that calcium to phosphate ratio (Ca:P) 
ranged from 1.5 to 2.0, with a mean value of around 1.71. 
The ideal Ca:P ratio for HAP is 1.67 [50], which is 
approximately 2.4% smaller than the 1.71 determine using 
the present conversion process. 
3.3. FT-IR and TEM Analysis of DCPD Formation 
Analysis of the FT-IR spectroscopy data was carried out 
to identify species, functional groups and vibration modes 
associated with each peak of the DCPD and HAP coatings. 
Figure 5 presents the results of the FT-IR analysis. 
Conversion of DCPD to HAP was confirmed by the 
appearance of a peak located at 601 cm-1 that corresponds to 
PO43- functional groups normally associated with HAP and 
not DCPD. TEM analysis of the DCPD coatings revealed 
that they were composed of plate-like structures that were 
configured in a flower-like feature. A TEM image of a 
single DCPD plate taken from a representative coating is 
presented in Figure 6 (a). Its appearance is solid, angular 
and typical of DCPD structures seen in the coatings. 
However, after chemical conversion the appearance and 
structure of the coating dramatically changes as seen in 
Figure 6 (b). The solid plate-like structure are transformed 
into a completely different morphology composed of HAP. 
 
Figure 5.  Results of FT-IR analysis showing the presence of PO43- 
functional groups at peak position 601 cm-1 characteristic of HAP 
formation 
3.4. Corrosion Resistance of Coatings 
To be an effective biodegradable material an Mg based 
implant must slowly degrade and allow regenerating bone 
tissues to progressively take over from the load carrying 
function of the implant. To achieve this objective the 
corrosion rate of the Mg implant must be effectively 
controlled and allow sufficient time for successful tissue 
regeneration to take place. Furthermore, by effectively 
controlling the corrosion rate of a biodegradable implant 
means that it is possible to avoid the long-term 
complications normally associated with conventional metal 
implants. This study has examined the performance of two 
CaP coatings in reducing the effects of corrosion on Mg 
substrates in PBS and Ringer’s solutions at 37ºC. 
Representative potentio-dynamic polarization curves 
produced by the corrosion tests for Mg substrates with and 
without CaP coatings are presented in Figure 7.  
 
Figure 6.  TEM images taken before and after conversion: (a) a typical 
plate-like structure associated with DCPD coating, and (b) a typical HAP 
structure seen after the conversion process 
Figure 7 (a) presents the PBS solution test results and 
clearly show a significant improvement in corrosion 
resistance of coated substrates. The DCPD coating provided 
the superior corrosion resistance compared to the HAP 
coating. The calculated corrosion rate for DCPD coatings 
were found to be 0.126 mm/yr and was a significant 
improvement over the 1.829 mm/yr for the uncoated Mg 
substrate. Importantly, the corrosion rate of the DCPD 
coating was half the value found for the equivalent HAP 
coating as seen in Table 1. 
Table 1.  Corrosion rates of DCPD and HAP coated Mg substrates 





Humid air [51] Mg substrate 1.0 x 10-5 
Distilled water [51] Mg substrate 1.5 x 10-2 




Mg substrate 1.829 
DCPD coated Mg substrate 0.126 
HAP coated Mg substrate 0.279 
Ringer’s solution 
(This study) 
Mg substrate 3.828 
DCPD coated Mg substrate 0.1 
HAP coated Mg substrate 0.264 
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The second electrolyte used in examining corrosion 
behaviour of substrates was Ringer’s solution. The Ringer’s 
solution test results are presented in Figure 7 (b). Like the 
PBS solution results, corrosion testing in Ringer’s solution 
also confirmed a significant improvement in corrosion 
resistance of coated substrates. The results also confirmed 
DCPD coatings were superior to HAP coating. In Ringer’s 
solution, uncoated Mg substrates had the highest corrosion 
rate of 3.828 mm/yr. And again DCPD coated substrate’s 
had a corrosion rate (0.1 mm/yr.) that was slightly less than 
half of an equivalent HAP coating (0.264 mm/yr.) as seen in 
Table 1. Corrosion studies confirmed that uncoated 
substrates found both PBS and Ringer’s solutions highly 
aggressive. Similarly, body fluids are similar in nature to 
the test solutions and are as equally aggressive towards 
uncoated Mg. However, the corrosion studies have shown 
that both DCPD and HAP coatings have the potential to 
significantly reduce the degradation rate of Mg substrates in 
PBS and Ringer’s solutions. It is expected that there would 
be a similar reduction in corrosion rates for DCPD and HAP 
coated substrates in vivo. However, further studies are 
needed to investigate and quantify degradation behaviour in 
vivo. 
 
Figure 7.  Polarization curves produced during the corrosion tests carried 
out in (a) Phosphate buffer saline (PBS) solution and (b) Ringer’s solution 
for both DCPD and HAP coated magnesium substrates 
4. Conclusions 
The corrosion rate of Mg substrates in PBS and Ringer’s 
solutions at 37ºC was significantly reduced by the presence 
of a DCPD or HAP coating. The initial DCPD coatings 
were formed via a straightforward chemical immersion 
technique. The coatings were subsequently converted to 
HAP via a low-temperature hydrothermal process in order 
to examine which coating had the most effective corrosion 
resistance. FT-IR analysis was used to confirm DCPD 
conversion to HAP. Corrosion studies revealed that DCPD 
coated substrates had the lowest corrosion rate in both PBS 
(0.126 mm/yr) and Ringer’s solution (0.1 mm/yr) compared 
to HAP coated and uncoated Mg substrates. Both DCPD 
and HAP coatings have the capacity to significantly reduce 
the corrosive effects of PBS solution and Ringer’s solution. 
Since both these solutions are similar in nature to body 
fluids, the corrosion studies suggest that both coatings have 
the potential to reduce similar corrosive effects found in the 
body environment. However, further in vivo studies are 
needed to fully study and quantify the corrosive effects of 
actual body fluids on DCPD and HAP coatings formed in 
this study. This is of particular importance since Mg based 
degradable implants with DCPD and HAP coatings offer 
the potential to significantly improve biocompatibility and 
promote bone formation during tissue regeneration in hard 
tissue trauma treatments.  
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